Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy
Molecular Therapy · 2026-08 · 34 (8) · 4372-4373
DOI: 10.1016/j.ymthe.2026.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Afsar U Ahmed. Beteiligte Einrichtung: Department of Microbiology, Anatomy, Physiology and Pharmacology (MAPP), School of Agriculture, Biomedicine and Environment (SABE), La Trobe Universi…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Microbiology, Anatomy, Physiology and Pharmacology (MAPP), School of Agriculture, Biomedicine and Environment (SABE), La Trobe University, Bundoora, VIC 3086, Australia; Aeterna Health Services Pty Ltd, Bi…
Zitieren
APA
Ahmed, A. U. (2026). Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy. Molecular Therapy, 34(8), 4372-4373. https://doi.org/10.1016/j.ymthe.2026.07.007
Vancouver
Ahmed AU. Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy. Molecular Therapy. 2026;34(8):4372-4373. doi:10.1016/j.ymthe.2026.07.007
BibTeX
@article{Ahmed2026,
author = {Ahmed, Afsar U},
title = {Decoding resistance in triple-negative breast cancer: NF-κB as a therapeutic target for oncolytic virotherapy},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {8},
pages = {4372--4373},
doi = {10.1016/j.ymthe.2026.07.007}
}
EUVIMED